Quick Answer
Processa Pharmaceuticals, Inc. reported Shares Outstanding of 2.57 million shares for fiscal year 2025.
Processa Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 2.57M | +1636.5% |
| 2024 | 148,108 | -88.5% |
| 2024 | 1.29M | +0.0% |
| 2023 | 1.29M | +60.4% |
| 2022 | 801,774 | -94.9% |
| 2021 | 15.71M | +10.8% |
| 2020 | 14.18M | +158.5% |
| 2019 | 5.49M | -0.7% |
| 2018 | 5.53M | -84.3% |
| 2017 | 35.27M | +11.1% |
| 2016 | 31.75M | +188.1% |
| 2015 | 11.02M | +0.6% |
| 2014 | 10.95M | +35.5% |
| 2013 | 8.08M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 52.86M | +1518.1% | +31.2% |
| June 30, 2025 | 40.28M | +1304.2% | +664.5% |
| March 31, 2025 | 5.27M | +84.5% | +42.3% |
| December 31, 2024 | 3.70M | +187.9% | +13.3% |
| September 30, 2024 | 3.27M | -86.7% | +13.9% |
| June 30, 2024 | 2.87M | -88.3% | +0.5% |
| March 31, 2024 | 2.86M | -88.4% | +122.1% |
| January 31, 2024 | 1.29M | — | +0.0% |
- Processa Pharmaceuticals, Inc. showed an increase of +1636.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Processa Pharmaceuticals, Inc.’s shares outstanding has declined by 68.2% (from 8.08 million shares to 2.57 million shares).
- The most recent figure is from Processa Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: